Patellofemoral Pain Syndrome. Chondromalacia patellae
Conditions
Interventions
Intervention 1: Control group: Electrotherapy: Initially, the patient receives TENS current for 20 minutes. 4 electrodes are placed around the knee at least 1 inch apart. Current settings will be 100-
Sponsors
Babol University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 45 Years
Inclusion criteria
Inclusion criteria: Age 18-45 years Increase in pain with at least two of the following movements: squatting, going up and down stairs, running, prolonged sitting, kneeling, jumping and landing Positive Clark's test (method: guide the patient's patella downwards. Then ask the patient to perform quadriceps contraction. The presence or exacerbation of pain is considered a positive test.) The patient has had pain in front of his knee for at least the last 3 months. The intensity of the patient's pain based on the VAS scale should be at least 3.5/10 and at most 7.4/10. They have not received physiotherapy in the past 6 months.
Exclusion criteria
Exclusion criteria: History of trauma, meniscus or ligament injury, or patellar tendinopathy Osteoarthritis in any of the lower limb joints History of Rheumatic or neurological diseases Lower back pain with/without referred pain to the leg History of surgery in any of the lower limbs Cognitive and psychological imbalance affecting the individual's functioning and perception.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain Intensity. Timepoint: Before starting and after the end of 6 weeks of intervention. Method of measurement: Visual Analogue Scale. | — |
Secondary
| Measure | Time frame |
|---|---|
| Disability. Timepoint: before the beginning and after the end of 6 weeks of intervention. Method of measurement: Anterior Knee Pain Questionnaire (Kujala).;Tactile Acuity. Timepoint: before the beginning and after the end of 6 weeks of intervention. Method of measurement: caliper.;Central Sensitization. Timepoint: before the beginning and after the end of 6 weeks of intervention. Method of measurement: Central Sensitization Inventory Questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMaryam Abbaszadeh-Amirdehi
Babol University of Medical Sciences
Outcome results
None listed